Back

Prescription rates of guideline-directed medical treatment across the eGFR continuum in patients with heart failure: Insights from the MISOAC-AF trial

23 May 2022 (08:30 - 19:45)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Chronic Heart Failure 9 Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Dimitrios Moysidis

University Hospital Zurich, Zurich (Switzerland)

35 More presentations in this session

Presentation thumbnail
Clinical characteristics of HFrEF patients with monogenic rare variants in DCM genes: a subgroup analysis of the PARADIGM-HF trial
Doctor A. Barat (Dublin, IE)
Abstract Slides
Presentation thumbnail
Acute outflow graft occlusion- A novel complication of lysis therapy for treatment of LVAD pump thrombosis
Doctor I. Just-Lauer (Berlin, DE)
Abstract Slides
Presentation thumbnail
Sex specific protein differences in patients with an obese heart failure with preserved ejection fraction phenotype
Ms A. Schoeber (Mainz, DE)
Abstract Slides
Presentation thumbnail
Sodium-glucose cotransporter 2 inhibitors: the missing key for heart failure with reduced ejection fraction foundational therapy
Doctor P. Silverio Antonio (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Analysis of heart transplantation survival according to difference in age between donor and recipient
Doctor V. Donoso (Valencia, ES)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Chronic Heart Failure 9

The Event

Event poster

Heart Failure 2022

23 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources